Pediatric Asthma Score (PAS)
Assesses asthma exacerbation severity in children aged 2–18 to guide treatment intensity and disposition.
Score interpretation
→ PAS 5–7: Mild asthma exacerbation. Salbutamol MDI via spacer; observe 1 hour; discharge with action plan if good response.
→ PAS 8–11: Moderate asthma exacerbation. Salbutamol nebulisation every 20 minutes x3; ipratropium; oral prednisolone; reassess; consider admission.
→ PAS 12–15: Severe asthma exacerbation. Continuous nebulised salbutamol; IV magnesium sulphate; IV steroids; PICU alert; senior review immediately.
Interpretation bands for the PAS. Apply clinical judgement and local guidance.
References
Related
Curated clinical cross-links plus same-class fallbacks.
- Salbutamol (Paediatric — Asthma/Wheeze) · Short-Acting Beta-2 Agonist (SABA)
- Prednisolone (Paediatric) · Corticosteroid — Asthma Exacerbation / Croup / Nephrotic Syndrome / IBD
- Montelukast (Paediatric) · Leukotriene Receptor Antagonist — Asthma Prophylaxis / Allergic Rhinitis
- Poractant Alfa (Porcine Surfactant) · Lung Surfactant (Respiratory Distress Syndrome — Neonatal)
- Doxapram hydrochloride · Respiratory stimulant
- Tezepelumab (CRSwNP / Severe Asthma) · Anti-TSLP (Thymic Stromal Lymphopoietin) Monoclonal Antibody
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.